Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Clinical trial NCT05826964 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05826964
Sponsor: University of Miami
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer ER-positive Breast Cancer HER2-negative Breast Cancer Metastatic Breast Cancer

Start date: 2023-06-12
Primary completion: 2026-07-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.